EPITHELITIS

This adverse event was reported 21 times

These drugs are most commonly taken by patients reporting EPITHELITIS:

# Drug Count
0 DURVALUMAB 16
1 CARBOPLATIN 2
2 CLOPIDOGREL 2
3 CLOPIDOGREL BISULFATE 2
4 FLUOROURACIL 2
5 FLUOROURACIL CREAM, 0.5% 2
6 PEMBROLIZUMAB 2
7 PROPRANOLOL HYDROCHLORIDE 2
8 ROSUVASTATIN 2
9 ABEMACICLIB 1
See all common drugs associated with EPITHELITIS

EPITHELITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DURVALUMAB 16 0.0007
1 ABEMACICLIB 1 0.0000
2 RIBOCICLIB 1 0.0000
3 NEBIVOLOL HYDROCHLORIDE 1 0.0000
4 PROPRANOLOL HYDROCHLORIDE 2 0.0000
5 FLUOROURACIL CREAM, 0.5% 2 0.0000
6 FLUOROURACIL 2 0.0000
7 ZOLEDRONIC ACID 1 0.0000
8 ROSUVASTATIN 2 0.0000
9 LETROZOLE TABLETS 1 0.0000
See all drugs enriched for association with EPITHELITIS

EPITHELITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Programmed Death Ligand-1 Blocker [EPC] 16 0.0007
1 P2Y12 Platelet Inhibitor [EPC] 2 0.0000
2 Aromatase Inhibitor [EPC] 1 0.0000
3 Platinum-based Drug [EPC] 2 0.0000
4 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
5 HMG-CoA Reductase Inhibitor [EPC] 2 0.0000
6 beta-Adrenergic Blocker [EPC] 1 0.0000
See all drug classes enriched for association with EPITHELITIS